472 related articles for article (PubMed ID: 25645208)
21. Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
Snydman DR; McDermott LA; Jacobus NV
J Chemother; 2005 Dec; 17(6):614-21. PubMed ID: 16433191
[TBL] [Abstract][Full Text] [Related]
22. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Rand KH; Houck HJ
Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
[TBL] [Abstract][Full Text] [Related]
23. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
[TBL] [Abstract][Full Text] [Related]
24. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
Neudorfer K; Schmidt-Malan SM; Patel R
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
[TBL] [Abstract][Full Text] [Related]
25. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
Werth BJ; Shireman LM
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
Baltch AL; Smith RP; Ritz WJ; Bopp LH
Chemotherapy; 2001; 47(4):250-60. PubMed ID: 11399861
[TBL] [Abstract][Full Text] [Related]
28. Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an
Cusumano JA; Daffinee KE; Piehl EC; García-Solache M; Desbonnet C; Rice LB; LaPlante KL
Antimicrob Agents Chemother; 2022 Oct; 66(10):e0042622. PubMed ID: 36154173
[TBL] [Abstract][Full Text] [Related]
29. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
[TBL] [Abstract][Full Text] [Related]
30. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
[TBL] [Abstract][Full Text] [Related]
31. In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates.
Peiffer-Smadja N; Guillotel E; Luque-Paz D; Maataoui N; Lescure FX; Cattoir V
J Antimicrob Chemother; 2019 Dec; 74(12):3511-3514. PubMed ID: 31495901
[TBL] [Abstract][Full Text] [Related]
32. Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.
Kebriaei R; Rice SA; Singh KV; Stamper KC; Dinh AQ; Rios R; Diaz L; Murray BE; Munita JM; Tran TT; Arias CA; Rybak MJ
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760141
[No Abstract] [Full Text] [Related]
33. In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci.
Cilli F; Aydemir S; Tunger A
J Chemother; 2006 Feb; 18(1):27-32. PubMed ID: 16572890
[TBL] [Abstract][Full Text] [Related]
34. Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes.
Barber KE; Werth BJ; Ireland CE; Stone NE; Nonejuie P; Sakoulas G; Pogliano J; Rybak MJ
J Antimicrob Chemother; 2014 Nov; 69(11):3006-10. PubMed ID: 24990867
[TBL] [Abstract][Full Text] [Related]
35. Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.
Hall Snyder AD; Werth BJ; Nonejuie P; McRoberts JP; Pogliano J; Sakoulas G; Yim J; Singh N; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5716-23. PubMed ID: 27431211
[TBL] [Abstract][Full Text] [Related]
36. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
Rand KH; Houck H
J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
[TBL] [Abstract][Full Text] [Related]
37. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.
Pankey G; Ashcraft D; Patel N
Antimicrob Agents Chemother; 2005 Dec; 49(12):5166-8. PubMed ID: 16304195
[TBL] [Abstract][Full Text] [Related]
38. The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection.
Chuang YC; Wang JT; Yang JL; Lin CY; Huang SH; Chen YC; Chang SC
J Infect Public Health; 2022 Dec; 15(12):1396-1402. PubMed ID: 36371936
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model.
Meyer KA; Deraedt MF; Harrington AT; Danziger LH; Wenzler E
Int J Antimicrob Agents; 2019 Aug; 54(2):197-201. PubMed ID: 31034937
[TBL] [Abstract][Full Text] [Related]
40. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
Luther MK; Arvanitis M; Mylonakis E; LaPlante KL
Antimicrob Agents Chemother; 2014 Aug; 58(8):4612-20. PubMed ID: 24867993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]